Does DUPILUMAB Cause Injection site warmth? 889 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 889 reports of Injection site warmth have been filed in association with DUPILUMAB (Dupixent). This represents 0.2% of all adverse event reports for DUPILUMAB.
889
Reports of Injection site warmth with DUPILUMAB
0.2%
of all DUPILUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Injection site warmth From DUPILUMAB?
Of the 889 reports, 15 (1.7%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 889 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
GALCANEZUMAB-GNLM (197)
Which DUPILUMAB Alternatives Have Lower Injection site warmth Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE